| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/14/2005 | EP1572226A2 Peptides having a high cysteine content |
| 09/14/2005 | EP1572201A1 Pharmaceutical compositions of sertaconazole for vaginal use |
| 09/14/2005 | EP1572192A1 Controlled release preparations comprising tramadol and topiramate |
| 09/14/2005 | EP1572178A2 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 09/14/2005 | EP1572170A2 Immunotoxin as a therapeutic agent and uses thereof |
| 09/14/2005 | EP1572165A1 New film coating |
| 09/14/2005 | EP1572159A1 Stable topiramate formulations |
| 09/14/2005 | EP1572154A2 Medical devices employing novel polymers |
| 09/14/2005 | EP1572151A1 Liquid dosage forms of proton pump inhibitors |
| 09/14/2005 | EP1572124A2 Hcv e1e2 vaccine compositions |
| 09/14/2005 | EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides |
| 09/14/2005 | EP1572093A2 Improved treatment of cancer with glutamine |
| 09/14/2005 | EP1572087A2 Antibodies against cancer antigen tmeff2 and uses thereof |
| 09/14/2005 | EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 09/14/2005 | EP1572077A2 Uses of monoclonal antibody 8h9 |
| 09/14/2005 | EP1572074A2 Stabilized synthetic immunogen delivery system |
| 09/14/2005 | EP1572067A2 Conjugates and compositions for cellular delivery |
| 09/14/2005 | EP1571968A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/14/2005 | EP1571929A1 A process for the preparation of antioxidant conserve from indian curry leaves (murraya koenigii spreng.) |
| 09/14/2005 | EP1515698A4 Liposomes containing biologically active compounds |
| 09/14/2005 | EP1498142A4 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 09/14/2005 | EP1438060A4 Prevention and treatment of restenosis by local administration of drug |
| 09/14/2005 | EP1383537A4 Novel chocolate composition as delivery system for nutrients and medications |
| 09/14/2005 | EP1198488B1 Biodegradable block copolymers with modifiable surface |
| 09/14/2005 | EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants. |
| 09/14/2005 | EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer |
| 09/14/2005 | EP1073418A4 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 09/14/2005 | EP1030676B1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 09/14/2005 | CN1668721A Immunoadhesin comprising a glycoprotein VI domain |
| 09/14/2005 | CN1668697A Synthetic matrix for controlled cell ingrowth and tissue regeneration |
| 09/14/2005 | CN1668643A Method for using glucan-haemoglobin conjugale as blood substitute |
| 09/14/2005 | CN1668598A Use of chemotherapeutic agents |
| 09/14/2005 | CN1668339A Steroid conjugates, preparation thereof and the use thereof |
| 09/14/2005 | CN1668336A Drug transport and delivery system |
| 09/14/2005 | CN1668335A Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 09/14/2005 | CN1668334A Transdermal absorption preparation |
| 09/14/2005 | CN1668333A Stable pharmaceutical composition comprising erythropoietin |
| 09/14/2005 | CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine |
| 09/14/2005 | CN1668331A Hapten-carrier conjugates and uses thereof |
| 09/14/2005 | CN1668327A Transdermal botulinum toxin compositions |
| 09/14/2005 | CN1668320A Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 09/14/2005 | CN1668292A Soluble stable pharmaceutical composition for the administration of HIV protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of HIV |
| 09/14/2005 | CN1668289A Modafinil pharmaceutical compositions |
| 09/14/2005 | CN1668285A Lasofoxifene tablet and its coating |
| 09/14/2005 | CN1668283A Pharmaceutical compositions with improved dissolution |
| 09/14/2005 | CN1668279A Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| 09/14/2005 | CN1668278A Bioerodible film for ophthalmic drug delivery |
| 09/14/2005 | CN1668277A Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 09/14/2005 | CN1668276A Injectable depot compositions and uses thereof |
| 09/14/2005 | CN1668275A Composition and method for controlled release injections |
| 09/14/2005 | CN1668257A Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 09/14/2005 | CN1668213A Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 09/14/2005 | CN1219072C Digestion tolerant starch and its preparation method and uses |
| 09/14/2005 | CN1219039C Grease of ageratum nut and its preparation method and usage |
| 09/14/2005 | CN1218752C Compound function supermicro magnetic carrier particle and its preparing method |
| 09/14/2005 | CN1218699C Method for increasing solubility of parabuxinidine-D injection |
| 09/14/2005 | CN1218696C Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/14/2005 | CN1218694C Method for treating endometriosis or infertility, or improving fertility |
| 09/14/2005 | CN1218693C Adhesive film agent of Chinese traditional medicine and its preparing method |
| 09/14/2005 | CN1218692C Film coating |
| 09/14/2005 | CN1218691C Dual-layer slow releasing tablet of benproperine phosphate |
| 09/14/2005 | CN1218689C Pharmaceutical compositions containing tobramycin and xanthan gum |
| 09/13/2005 | US6943211 polymer strands formed from at least one ethylenically unsaturated monomer(when titrated with a base form negatively charged groups) and linking the polymer strands by at least one linking group containing a hydrolytically susceptible bond |
| 09/13/2005 | US6943197 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses |
| 09/13/2005 | US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/13/2005 | US6943164 Pharmaceutical solutions of levosimendan |
| 09/13/2005 | US6943155 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity |
| 09/13/2005 | US6943154 Water insoluble derivatives of polyanionic polysaccharides |
| 09/13/2005 | US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity |
| 09/13/2005 | US6943145 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 09/13/2005 | US6943027 Contacting a nucleic acid with an organic polycation to produce a condensed nucleic acid, and then combining product with an amphiphilic cationic lipid; increased shelf life and high transfection activity |
| 09/13/2005 | US6942985 Diagnosisng colon or rectal cancer in mammals; obtain tissue sample, detect concentration of preferential receptor protein, amplified concentration of protein indicates cancer |
| 09/13/2005 | US6942972 Preparation of oligonucleotide-protein conjugate; obtain oligonucleotide expose to linker, join, expose oligonucleotide-linker conjugate with preferential protein, join, recover oligonucleotide-protein conjugate |
| 09/13/2005 | US6942877 Method for producing antibiotic composites |
| 09/13/2005 | US6942874 Nucleotides consist of a purine or pyrimidine group, or derivative thereof, and an ionizable phosphate or other anionic organic molecule. |
| 09/13/2005 | US6942868 Aerodynamically light particles for pulmonary drug delivery |
| 09/13/2005 | US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli |
| 09/13/2005 | US6942165 Generation of therapeutic microfoam |
| 09/13/2005 | US6941948 Medicament storage and delivery devices |
| 09/13/2005 | CA2469019C Pharmaceutical composition comprising a 5ht1 receptor agonist |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2368650C Viral treatment |
| 09/13/2005 | CA2316190C Biodegradable shape memory polymers |
| 09/13/2005 | CA2235919C Non-polymeric sustained release delivery system |
| 09/13/2005 | CA2193502C Sphingosomes for enhanced drug delivery |
| 09/13/2005 | CA2173254C Immunological tolerance-inducing agent |
| 09/13/2005 | CA2102186C Nanoparticles having a prolonged reticulo-endothelial system capture rate |
| 09/09/2005 | WO2005083431A2 Binding agents |
| 09/09/2005 | WO2005083103A1 Method for the production of hyperbranched polysaccharide fractions |
| 09/09/2005 | WO2005082942A2 Hydroxyethyl starch |
| 09/09/2005 | WO2005082428A2 Plaster that reduces skin irritation |
| 09/09/2005 | WO2005082423A2 Serum albumin conjugated to fluorescent substances for imaging |
| 09/09/2005 | WO2005082421A1 Use of organo-silicon compounds for constraining connective damaged tissues |
| 09/09/2005 | WO2005082420A1 Stable pharmaceutical composition comprising an ace inhibitor |
| 09/09/2005 | WO2005082419A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
| 09/09/2005 | WO2005082418A1 Long-acting solid formulation comprising triptorelin acetate |
| 09/09/2005 | WO2005082417A1 Directly-compressible xylitol powder |
| 09/09/2005 | WO2005082416A2 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
| 09/09/2005 | WO2005082405A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same |
| 09/09/2005 | WO2005082383A1 A medical solution, a method for producing said medical solution and use thereof |